Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients

Blood

Volumn 117, Issue 19, 2011, Pages 5050-5056

  Choi, Su Mi ^a,b   Boudreault, Alexandre A ^a,c   Xie, Hu ^a   Englund, Janet A ^d   Corey, Lawrence ^a,d,e   Boeckh, Michael ^a,e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b The Catholic University of Korea   (South Korea)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BECLOMETASONE DIPROPIONATE; METHYLPREDNISOLONE; OSELTAMIVIR; PREDNISONE; RIMANTADINE; ZANAMIVIR;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOXEMIA; INFLUENZA A (H1N1); INFLUENZA B; LOW DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; VIRUS SHEDDING;

EID: 79955972415     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-319186     Document Type: Article

References (47)

1. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol. 2008;143:455-467.
2. Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med. 2007;28:222-242. (Pubitemid 46676916)
3. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004; 39(9):1300-1306. (Pubitemid 39458515)
4. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood. 2007;110(5): 1681-1688. (Pubitemid 47443987)
5. Casper C, Englund J, Boeckh M. How I treat influenza in patients with hematologic malignancies. Blood. 2010;115(7):1331-1342.
6. Chemaly RFGS, Bodey GP, Rohatgi N, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006; 85(5):278-287. (Pubitemid 44401460)
7. Espinosa-Aguilar L, Green J, Forrest GN, et al. Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experience. Biol Blood Marrow Transplant. 2011;17(4): 566-573.
8. Raphael D. Chapter 180. Influenza. In: Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 17th ed. McGraw-Hill Co Inc, New York, NY; 2008:1127-1132.
9. Writing Committee of the World Health Organization Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353(13):1374-1385.
10. Jeannette G, Reynaldo F-E. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res. 2009;40(8): 655-661.
11. Munster VJ, de Wit E, van den Brand JMA, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science. 2009;325(5939):481-483.
12. Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science. 2009;325(5939):484-487.
13. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460(7258):1021-1025.
14. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(32):893-896.
15. Boudreault AA, Xie H, Leisenring W, Englund J, Corey L, Boeckh M. Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus [published online ahead of print September 23, 2010]. Biol Blood Marrow Transplant. doi: 10.1016/j.bbmt.2010.09.014.
16. Renaud C, Pergam SA, Polyak C, et al. Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir. Transplant Infect Dis. 2010; 12(6):513-517.
17. Campbell AP, Jacob ST, Kuypers J, et al. Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: detection of extrapulmonary H1N1 RNA and use of intravenous peramivir. Ann Intern Med. 2010;152(9):619-620.
18. Kuypers J, Wright N, Ferrenberg J, et al. Comparison of real-time PCR assays with fluorescentantibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol. 2006; 44(7):2382-2388. (Pubitemid 44109661)
19. Hockenbery DM, Cruickshank S, Rodell TC, et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisonesparing therapy for gastrointestinal graft-versushost disease. Blood. 2007;109(10):4557-4563. (Pubitemid 46743427)
20. Chien JW, Sakai M, Gooley TA, Schoch HG, McDonald GB. Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials. Bone Marrow Transplant. 2010;45(2):317-324.
21. McDonald GB. Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation. Expert Opin Investig Drugs. 2007;16(10):1709-1724. (Pubitemid 350028418)
22. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood. 2001;98(3):573-578.
23. Lee N, Chan P, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009;200(4):492-500.
24. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009;9:493-504.
25. Ljungman P. Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant. 2001;7(suppl 1): 5S-7S.
26. Elting LS, Whimbey E, Lo W, Couch R, Andreeff M, Bodey GP. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer. 1995;3(3):198-202.
27. Update: influenza activity - United States, 2009-10 season. MMWR Morb Mortal Wkly Rep. 2010;59(29):901-908.
28. Shiley K, Nadolski G, Mickus T, Fishman N, Lautenbach E. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. 2010. Infect Control Hosp Epidemiol. 2010;31(7):676-682.
29. Strouse JJ, Reller ME, Bundy DG, et al. Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease. Blood. 2010;116(18):3431-3434.
30. Redelman-Sidi G, Sepkowitz KA, Huang CK, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010;60(4):257-263.
31. George B, Ferguson P, Kerridge I, Gilroy N, Gottlieb D, Hertzberg M. The clinical impact of infection with Swine flu (H1N1 09) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2011; 17(1):147-153.
32. Suyani E, Aki Z, Guzel O, Altindal S, Senol E, Sucak G. H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving [published online ahead of print September 6, 2010]. Transpl Infect Dis. doi:10.1111/j.1399-3062.2010.00569.x.
33. Rihani R, Hayajneh W, Sultan I, et al. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience [published online ahead of print January 17, 2011]. Bone Marrow Transplant. doi: 10.1038/bmt.2010.329.
34. Morrison C, Maurtua-Neumann P, Myint MT, Drury SS, Begue RE. Pandemic (H1N1) 2009 outbreak at camp for children with hematologic and oncologic conditions. Emerg Infect Dis. 2011; 17(1):87-89.
35. Cost C, Brock E, Adams-Huet B, Siegel JD, Ardura MI. 2009 pandemic influenza a (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatr Blood Cancer. 2011;56(1):127-133.
36. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010; 10(8):521-526.
37. Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transpl. 2010;10(1):18-25.
38. Nguyen JT, Hoopes JD, Smee DF, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother. 2009;53(10):4115-4126.
39. Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis. 2009;48(suppl 1):S3-S13.
40. Nguyen JTHJ, Le MH, Smee DF, et al. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS ONE. 2010;5(2):e9332.
41. Poland G, Jacobson R, Ovsyannikova I. Influenza virus resistance to antiviral agents: a plea for rational use. Clin Infect Dis. 2009;48(9):1254- 1256.
42. Adisasmito W, Chan PK, Lee N, et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis. 2010;202(8):1154-1160.
43. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, Yuen KY. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis. 2010;201(3): 346-353.
44. Chan KH, Zhang AJ, To KK, et al. Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLoS ONE. 2010;5(10):e13757.
45. Hagau N, Slavcovici A, Gonganau DN, et al. Clinical aspects and cytokines response in severe H1N1 influenza A virus infection. Crit Care. 2010; 14(6):R203.
46. Quispe-Laime A, Bracco J, Barberio P, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med. 2010;36(1):33-41.
47. Triana-Baltzer GB, Gubareva LV, Nicholls JM, et al. Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS ONE. 2009;4(11):e7788.